Barrington Initiates a Buy Rating on Option Care Health Inc (BIOS)

Option Care Health Inc (BIOSResearch Report) received a Buy rating and a $4 price target from Barrington analyst Michael Petusky today. The company’s shares closed last Monday at $3.40.

Petusky noted:

“We certainly think that there is upside to this back‐of‐the envelope estimate.”

According to, Petusky is a 4-star analyst with an average return of 4.4% and a 52.8% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics Inc, Varian Medical Systems, and Merit Medical Systems.

Option Care Health Inc has an analyst consensus of Moderate Buy, with a price target consensus of $4.25.

See today’s analyst top recommended stocks >>

Based on Option Care Health Inc’s latest earnings release for the quarter ending June 30, the company reported a quarterly GAAP net loss of $15.67 million. In comparison, last year the company had a GAAP net loss of $15.14 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.